SCHEMBL1004909

SCHEMBL1004909

Br[Mg]c1cccc(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL1557458 0.84 HTT (0.35)
SCHEMBL31324642 0.77
SCHEMBL1868904 0.77
SCHEMBL5000 0.73
SCHEMBL64291 0.72
SCHEMBL37679 0.72
SCHEMBL10352959 0.72
SCHEMBL31693851 0.72
SCHEMBL9574887 0.72
Bromide SCHEMBL11152275 0.70 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105622334-A Synthetic method of 3-bromo-9,9'-spirobifluorene INST OF CHEMISTRY CO LTD HENAN ACAD OF SCIENCES 2016-06-01 CN claimed
US-6458962-B1 VIRICIDES FOR TREATMENT OF AIDS AND HYDROGENATION OF COMPOUNDS THE UNIVERSITY OF TENNESSEEE RESEARCH CORPORATION 2002-10-01 US claimed
WO-2000056332-A1 SULTAMS: CATALYST SYSTEMS FOR ASYMMETRIC REDUCTION OF A C=N INTERMEDIATE BIOLOGICAL COMPOSITIONS AND METHODS FOR MAKING THE SULTAMS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2000-09-28 WO claimed
JP-5255331-A None JP disclosed
EP-4709720-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2026-03-18 EP disclosed
WO-2024233846-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES, INC. (US) 2024-11-14 WO disclosed
WO-2024200777-A1 SUBSTITUTED HYDROXYMETHYL PYRROLIDINES FOR USE IN THE TREATMENT OF HYPERGLYCAEMIA AND DISORDERS CHARACTERISED BY HYPERGLYCAEMIA ATROGI AB (SE) 2024-10-03 WO disclosed
CN-111372932-B Novel benzylamino-substituted pyridopyrimidinones and derivatives as SOS1 inhibitors 勃林格殷格翰国际有限公司 2023-11-21 CN disclosed
US-11814380-B2 Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-11-14 US disclosed
US-20230293522-A1 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-09-21 US disclosed
EP-4219493-A1 BENZYLAMINO SUBSTITUTED PYRIDOPYRIMIDINONES AND DERIVATIVES AS SOS1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2023-08-02 EP disclosed
US-5334590-A MRSA active 2-phenyl-carbapenems MERCK & CO., INC. (US) 1994-08-02 US disclosed
US-5256777-A Bactericides MERCK & CO., INC. (US) 1993-10-26 US disclosed
JP-H05255331-A MRSA ACTIVE 2-HALOPHENYLCARBAPENEM MERCK & CO INC 1993-10-05 JP disclosed
EP-0538016-A1 MRSA active 2-phenyl-carbapenems MERCK & CO. INC. (US) 1993-04-21 EP disclosed
EP-0538001-A1 MRSA active 2-halophenyl carbapenems MERCK & CO. INC. (US) 1993-04-21 EP disclosed
EP-0024943-B1 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TORAY INDUSTRIES, INC. (JP) 1983-08-17 EP disclosed
US-4301164-A FOR USE AS ANTIULCER AGENTS, HYPOTENSIVE AGENTS, ANTITHROMBOSIC AGENTS TORAY INDUSTRIES, INC. (JP) 1981-11-17 US disclosed
EP-0024943-A1 5,6,7-Trinor-4,8-inter-m-phenylene PGI2 derivatives and pharmaceutical compositions containing them TORAY INDUSTRIES, INC. (JP) 1981-03-11 EP disclosed
US-3974143-A (16α)-16,17-ALKYLIDENEBIS(OXY)-3-ARYLPREGNA-2,4-TRIEN-20-ONES G. D. SEARLE & CO. (US) 1976-08-10 US disclosed